Sign up

First Turn Management, LLC

$934.7M assets · 31 holdings · Q2 2026 · Filed 14 AUG 2026

About First Turn Management, LLC’s 13F portfolio

First Turn Management, LLC is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , First Turn Management, LLC reported $934.7M across 31 US-listed positions (). Its largest position is REVOLUTION MEDICINES INC (RVMD) at 8.3% of the reported book, and its ten biggest holdings make up 54% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.

$934.7M
Assets (13F)
#2,471
of 8,839 by size
31
Holdings
54%
Top-10 weight
19
Buys
19
Sells
Top holdings · Q2 2026
31 total
#StockPrice% of portfolioSharesValue
1
NASDAQ: RVMD
REVOLUTION MEDICINES INC
$159.82
−1.76%
8.3%
415K$77.8M
2
NASDAQ: ABVX
ABIVAX SA
$83.83
+2.11%
7.0%
490K$65.3M
3
NASDAQ: AXSM
AXSOME THERAPEUTICS INC.
$134.00
−1.43%
5.7%
218K$53.5M
4
NASDAQ: ELVN
ENLIVEN THERAPEUTICS INC
$44.89
−4.18%
5.2%
954K$48.4M
5
NASDAQ: BBIO
BRIDGEBIO PHARMA INC
$78.01
+1.58%
5.0%
633K$47.2M
6
NASDAQ: ROIV
ROIVANT SCIENCES LTD
$38.73
+0.05%
5.0%
1.3M$47.1M
7
NASDAQ: UTHR
UNITED THERAPEUTICS CORP DEL
$577.34
−1.16%
4.9%
85K$46.0M
8
NASDAQ: CYTK
CYTOKINETICS INC
$51.32
−0.64%
4.8%
527K$44.9M
9
NASDAQ: XENE
XENON PHARMACEUTICALS INC
$37.75
−2.66%
3.9%
600K$36.2M
10
NASDAQ: CELC
CELCUITY INC
$55.60
−4.15%
3.7%
329K$34.4M
11
NASDAQ: VRDN
VIRIDIAN THERAPEUTICS INC
$30.12
+0.20%
3.3%
1.7M$30.7M
12
NASDAQ: INSM
INSMED INC
$119.80
−1.69%
3.0%
264K$28.1M
13
NASDAQ: QURE
UNIQURE NV
$20.30
−2.31%
3.0%
609K$28.0M
14
NASDAQ: ASND
ASCENDIS PHARMA A/S
$270.33
−0.32%
3.0%
105K$28.0M
15
NASDAQ: PRAX
PRAXIS PRECISION MEDICINES I
$305.19
+0.04%
3.0%
84K$28.0M
16
NASDAQ: DNTH
DIANTHUS THERAPEUTICS INC
$83.98
−3.45%
3.0%
286K$27.9M
17
NASDAQ: PCVX
VAXCYTE INC
$58.52
−1.48%
2.8%
444K$25.8M
18
NASDAQ: MIRM
MIRUM PHARMACEUTICALS INC
$92.49
+0.59%
2.7%
218K$25.5M
19
NASDAQ: PVLA
PALVELLA THERAPEUTICS INC NE
$146.58
+1.54%
2.6%
156K$23.9M
20
NASDAQ: COGT
COGENT BIOSCIENCES INC
$27.81
−0.14%
2.5%
602K$23.3M
21
NASDAQ: ERAS
ERASCA INC
$13.76
−0.94%
2.4%
1.2M$22.4M
22
NASDAQ: ORIC
ORIC PHARMACEUTICALS INC
$7.65
−4.37%
2.3%
2.0M$21.8M
23
NASDAQ: NAMS
NEWAMSTERDAM PHARMA COMPANY
$19.74
+1.81%
2.1%
582K$19.7M
24
NASDAQ: APGE
APOGEE THERAPEUTICS INC
$135.07
0.00%
2.0%
139K$18.4M
25
NASDAQ: RYTM
RHYTHM PHARMACEUTICALS INC
$119.04
+2.08%
1.8%
154K$17.1M

Showing 1–25 of 31 positions on this page reported in this 13F.

Sector allocation
  • Healthcare100%
Recent activity · vs 2026-03-31
Bought19
  • AddedABVXABIVAX SA+5.2%$65.3M
  • AddedAXSMAXSOME THERAPEUTICS INC.+15.7%$53.5M
  • AddedELVNENLIVEN THERAPEUTICS INC+53.0%$48.4M
  • AddedROIVROIVANT SCIENCES LTD+11.8%$47.1M
  • AddedCYTKCYTOKINETICS INC+85.9%$44.9M
  • AddedCELCCELCUITY INC+56.3%$34.4M
  • AddedVRDNVIRIDIAN THERAPEUTICS INC+83.2%$30.7M
  • AddedINSMINSMED INC+6.2%$28.1M
  • NewASNDASCENDIS PHARMA A/S—$28.0M
  • AddedPRAXPRAXIS PRECISION MEDICINES I+96.8%$28.0M
Sold19
  • ReducedRVMDREVOLUTION MEDICINES INC−11.3%$77.8M
  • ReducedBBIOBRIDGEBIO PHARMA INC−9.0%$47.2M
  • ReducedUTHRUNITED THERAPEUTICS CORP DEL−18.9%$46.0M
  • ReducedXENEXENON PHARMACEUTICALS INC−23.7%$36.2M
  • ReducedQUREUNIQURE NV−1.1%$28.0M
  • ReducedMIRMMIRUM PHARMACEUTICALS INC−45.6%$25.5M
  • ReducedCOGTCOGENT BIOSCIENCES INC−36.4%$23.3M
  • ReducedAPGEAPOGEE THERAPEUTICS INC−73.0%$18.4M
  • ReducedSRRKSCHOLAR ROCK HLDG CORP−39.2%$14.9M
  • ReducedKYMRKYMERA THERAPEUTICS INC−59.7%$11.8M

Reading First Turn Management, LLC’s 13F portfolio

First Turn Management, LLC’s $934.7M 13F book is spread across 31 reported positions and is concentrated toward its biggest ideas, with the top ten holdings at 54%. The largest positions carry real weight, so how those names perform matters a lot to the overall book. Its five largest positions are RVMD, ABVX, AXSM, ELVN and BBIO, led by REVOLUTION MEDICINES INC (RVMD) at 8.3% of the portfolio. The heaviest sector exposure is Healthcare (100%).

What First Turn Management, LLC changed last quarter

Between 2026-03-31 and Q2 2026, First Turn Management, LLC was roughly balanced between buying and selling: it opened 6 new positions and added to 13 more, while trimming 11 and closing 8 outright. Against a 31-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was ABIVAX SA (ABVX), and its biggest reduction was REVOLUTION MEDICINES INC (RVMD).

What a 13F does and doesn’t reveal

A 13F captures only First Turn Management, LLC’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names First Turn Management, LLC is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.

Frequently asked questions

What is an SEC 13F filing?

A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. First Turn Management, LLC's profile on this page is built directly from those filings.

How current is the 13F data on First Turn Management, LLC's page?

It reflects First Turn Management, LLC's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When First Turn Management, LLC files its next quarterly report, this page refreshes automatically.

Can I see First Turn Management, LLC's complete list of holdings?

This page highlights First Turn Management, LLC's largest positions rather than all 31 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under First Turn Management, LLC's filings.

Does a 13F show everything First Turn Management, LLC owns?

No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of First Turn Management, LLC's book rather than its full strategy or total assets.

Is 13F data investment advice?

No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why First Turn Management, LLC made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.

Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.